A multicenter prospective trial in the Netherlands has found that FDG-PET prevents unnecessary surgeries for one in six patients with metastatic colon cancer who undergo liver resection based on CT findings.
A multicenter prospective trial in the Netherlands has found that FDG-PET prevents unnecessary surgeries for one in six patients with metastatic colon cancer who undergo liver resection based on CT findings.
Dr. W.J.G. Oyen of Radboud University Nijmegen Medical Center and colleagues enrolled 75 surgical candidates randomly selected for assessment with CT alone, the standard imaging for recommending surgery, and another 75 who were evaluated with CT and FDG-PET. All 75 patients in the CT group underwent laparotomy compared to 70 in the PET group. Overall, surgeries for 34 (45%) and 21 (28%) patients performed on the basis of CT or CT plus PET, respectively, were considered futile. Disease recurred within six months in almost a third of patients in the CT-only group. Oyen presented results at the 2008 SNM meeting in New Orleans, Louisiana.
-By H.A. Abella
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.